Lipocine Inc. — Director's Dealing 2016

Jun 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2016-06-14

Reporting Person: Higuchi John W. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-14	Common Stock (right to buy)	$8.02	A	10000	Acquired	2026-06-13	Common Stock (10000)	Direct

Footnotes

F1: 100% vesting one year from date of grant